Patent Yard Sign in
Canadian application, no grantCanada

4-heterocyclophenyl-substituted dihydropyridines

CA 2109342 A1 · Owner: Junge, Bodo · Inventors: Hartwig, Wolfgang; Gao, Zhan; Schohe-Loop, Rudolf

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

4-Heterocyclophenyl-substituted dihydropyridines A b s t r a c t, 4-Heterocyclophenyl-substituted dihydropyridines are prepared either by reacting suitable aldehydes with amino esters and .beta.-keto esters, or preparing the heterocyclic substituents of the 4-phenyl by cyclization of corresponding amidines or hydrazides, or esterifying dihydropyridinecarboxylic acids, which are already substituted by heterocyclic radicals, with corresponding alcohols. The 4-heterocyclophenyl-substituted dihydropyridines can be employed in medicaments in, particular for treatment of diseases of the central nervous system.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 27, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 27, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 27, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 27, 1993
GrantedNo grant recorded
Term endedOctober 27, 2013
Patent numberCA 2109342 A1
Classification (IPC)C07D413/10 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedOct 27, 1993Term endedOct 27, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.